Vir Biotechnology to cut about 75 jobs, shut some facilities
13/12/2023 21:21
Dec 13 (Reuters) - Vir Biotechnology VIR.O said on Wednesday it will cut about 12% of its workforce, or about 75 positions, and reduce the number of sites it operates in, as part of its cost cut measures. (Reporting by Christy Santhosh; Editing by Shinjini Ganguli) ((Christy.Santhosh@thomsonreuters.com;))
Recent news on Vir Biotechnology
See all newsVir, Gilead team up on solid tumor cancer therapies in up to $1.9 billion deal
Vir Biotechnology gains after up to $1.9 billion licensing deal with Gilead
Brief: Vir Biotechnology Announces Psma-Targeted Pro-Xten® Dual-Masked T-Cell Engager Vir-5500 Received FDA Fast Track Designation For The Treatment Of Prostate Cancer
Brief: Vir Biotechnology Appoints David Liu As Chief Medical Officer
Vir Biotechnology rises after naming Theravance's Sawaf as CFO